Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02371863
Other study ID # NL39865.041.14
Secondary ID
Status Completed
Phase N/A
First received October 7, 2014
Last updated December 27, 2015
Start date December 2014
Est. completion date December 2015

Study information

Verified date December 2015
Source UMC Utrecht
Contact n/a
Is FDA regulated No
Health authority Netherlands: Medical Ethics Review Committee (METC)
Study type Observational

Clinical Trial Summary

Surgical treatment is the only approach with potentially defined clinical success for organic mitral valve (MV) regurgitation. Recurrent or persistent complaints after initial successful MV repair is a clinical challenge in current practice. Especially when echo parameters at rest are within or near normal ranges and patients presenting disproportionately symptomatic in relation to the observed results. However, while MV regurgitation is a hemodynamic disease, currently used 2-dimensional (2D) transthoracic echocardiography (TTE) at rest lacks information about hemodynamic changes. Physical stress echocardiography is a promising technique to complement nowadays rest TTE in order to improve interpretation of hemodynamic changes. However, normal values for exercise echo are lacking in this postoperative patients cohort. A prospective, observational trial to determine normal values in stress echocardiographic parameters in asymptomatic patients after successful MV repair for organic MV regurgitation, is therefore highly needed.

Purpose of the SEP- study is to determine normal values in stress echocardiographic parameters in asymptomatic patients at least 6 months after successful MV repair for organic MV regurgitation. These normal values for stress echo are of utmost importance to correctly and accurate interpret stress echo results during postoperative follow-up and to improve clinical decision making in patients post MV repair.


Recruitment information / eligibility

Status Completed
Enrollment 25
Est. completion date December 2015
Est. primary completion date December 2015
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Age =18 years;

- Male or female from all ethnicities;

- At least 6 months post successful, isolated MV repair. S

- Asymptomatic

Exclusion Criteria:

- Pulmonary hypertension >50 mmHg at rest;

- Atrial fibrillation (AF) at time of study related stress echo test;

- Known contraindication or incapability to perform peak exercise or inability to perform physical stress testing;

- LVEF <45%;

- NYHA class II and more.

- Other heart valve disease of more than mild severity;

- Concomitant surgery during MV repair, e.g. MAZE, TVP procedure;

- Prior heart valve surgery;

- Congenital heart disease;

- Disabling comorbidity, e.g. chronic obstructive pulmonary disease (COPD);

- Unable to provide informed consent

Study Design

Time Perspective: Cross-Sectional


Related Conditions & MeSH terms


Locations

Country Name City State
Netherlands University Medical Center Utrecht (UMC Utrecht) Utrecht

Sponsors (1)

Lead Sponsor Collaborator
UMC Utrecht

Country where clinical trial is conducted

Netherlands, 

Outcome

Type Measure Description Time frame Safety issue
Primary Echocardiographic parameter: Peak mitral valve mean gradient (mmHg) Echocardiographic measured mitral valve mean gradient at peak physical exercise at least 6 months after successful MV repair No
Primary Echocardiographic parameter: Peak systolic pulmonary artery pressure (sPAP, mmHg) Echocardiographic measured sPAP at peak physical exercise at least 6 months after successful MV repair No
Primary Echocardiographic parameter: Increase in mitral valve regurgitation grade (grade 0-4, according to ESC guidelines) Echocardiographic measured increase in mitral valve regurgitation at peak physical exercise during physical stress echo, compared to rest echo. Grading of mitral regurgitation will be performed according to the ESC guidelines. at least 6 months after successful MV repair No
Secondary Echocardiographic parameter: Left ventricular function (LVF, quality description) Echocardiographic measured LVF quality at rest and peak physical exercise at least 6 months after successful MV repair No
Secondary Echocardiographic parameter: Mitral valve area (MVA, cm2) Echocardiographic measured MVA at rest and peak physical exercise at least 6 months after successful MV repair No
Secondary Echocardiographic parameter: Peak mitral valve peak gradient (mmHg) Echocardiographic measured mitral valve peak gradient at peak physical exercise at least 6 months after successful MV repair No
See also
  Status Clinical Trial Phase
Not yet recruiting NCT02865798 - China Senile Valvular Heart Disease Cohort Study N/A
Completed NCT02249000 - BIOVALVE - I / II Clincial Investigation N/A
Completed NCT02297334 - Removal of Cytokines During Extracorporeal Circulation in Cardiac Surgery N/A
Completed NCT01591018 - SONOlysis in Risk REduction of Symptomatic and Silent Brain infarCtions dUring Cardiac surgEry Phase 3
Completed NCT01428947 - Does Coronary Angiography Cause Cognitive Dysfunction? N/A
Recruiting NCT01231776 - Acupuncture Improves Sleep in Patients Undergoing Cardiopulmonary Bypass N/A
Terminated NCT01116037 - ATS 3f(r) Aortic Bioprosthesis Model 1000 Post Approval Study N/A
Completed NCT00371891 - Ontario Multidetector Computed Tomographic (MDCT) Coronary Angiography Study (OMCAS) Phase 4
Terminated NCT03632967 - Early Feasibility Study of the Percutaneous 4Tech TriCinch Coil Tricuspid Valve Repair System N/A
Recruiting NCT05728047 - Evaluation of Systemic Microcirculation of Patients Undergoing Heart Valve Surgery
Not yet recruiting NCT05539261 - Research on Neurological Prognosis of Patients Undergoing Heart Valve Surgery
Completed NCT05479968 - Spectroscopic Assessment of Intramyocardial Oxygen Saturation Feasibility During Open-heart Surgery
Completed NCT03527381 - Nitric Oxide in Cardiopulmonary Bypass for Renal Protection in Cardiac Surgery Phase 1/Phase 2
Completed NCT03664102 - Automated Fastener Device Versus Manually Tied Knot in MiAVR
Recruiting NCT06084091 - Spectroscopic Assessment of Intramyocardial Oxygen Saturation During Open-Heart Surgery
Completed NCT05836467 - Is Myocardial Revascularization Really Necessary in Patients With ≥50-70% Coronary Stenosis Undergoing Valvular Surgery?
Recruiting NCT05933083 - MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation N/A
Recruiting NCT04445012 - Cardiovascular Acoustics and an Intelligent Stethoscope
Active, not recruiting NCT02732691 - JENAVALVE AS EFS TRIAL: Pericardial TAVR Aortic Stenosis Study N/A
Completed NCT02981953 - TRI-REPAIR: TrIcuspid Regurgitation RePAIr With CaRdioband Transcatheter System N/A